Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene - PubMed

Affiliations

• PMID: 16107576
• DOI: 10.1681/ASN.2005010055

Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene

Bryan L Wharram et al. J Am Soc Nephrol. 2005 Oct.

Abstract

Glomerular injury and proteinuria in diabetes (types 1 and 2) and IgA nephropathy is related to the degree of podocyte depletion in humans. For determining the causal relationship between podocyte depletion and glomerulosclerosis, a transgenic rat strain in which the human diphtheria toxin receptor is specifically expressed in podocytes was developed. The rodent homologue does not act as a diphtheria toxin (DT) receptor, thereby making rodents resistant to DT. Injection of DT into transgenic rats but not wild-type rats resulted in dose-dependent podocyte depletion from glomeruli. Three stages of glomerular injury caused by podocyte depletion were identified: Stage 1, 0 to 20% depletion showed mesangial expansion, transient proteinuria and normal renal function; stage 2, 21 to 40% depletion showed mesangial expansion, capsular adhesions (synechiae), focal segmental glomerulosclerosis, mild persistent proteinuria, and normal renal function; and stage 3, >40% podocyte depletion showed segmental to global glomerulosclerosis with sustained high-grade proteinuria and reduced renal function. These pathophysiologic consequences of podocyte depletion parallel similar degrees of podocyte depletion, glomerulosclerosis, and proteinuria seen in diabetic glomerulosclerosis. This model system provides strong support for the concept that podocyte depletion could be a major mechanism driving glomerulosclerosis and progressive loss of renal function in human glomerular diseases.

Comment in

• Role of podocytes in focal sclerosis: defining the point of no return.

  Kretzler M. Kretzler M. J Am Soc Nephrol. 2005 Oct;16(10):2830-2. doi: 10.1681/ASN.2005080841. Epub 2005 Sep 7. J Am Soc Nephrol. 2005. PMID: 16148037 Review. No abstract available.

Similar articles

• Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.

  Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, Kuick RD, Wiggins RC. Wiggins JE, et al. J Am Soc Nephrol. 2005 Oct;16(10):2953-66. doi: 10.1681/ASN.2005050488. Epub 2005 Aug 24. J Am Soc Nephrol. 2005. PMID: 16120818

• Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.

  Chen CA, Hwang JC, Guh JY, Chang JM, Lai YH, Chen HC. Chen CA, et al. J Lab Clin Med. 2006 Feb;147(2):74-82. doi: 10.1016/j.lab.2005.08.011. J Lab Clin Med. 2006. PMID: 16459165

• HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.

  Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I. Zuo Y, et al. J Am Soc Nephrol. 2006 Oct;17(10):2832-43. doi: 10.1681/ASN.2005080878. Epub 2006 Sep 20. J Am Soc Nephrol. 2006. PMID: 16988066

• [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].

  Ronconi E, Mazzinghi B, Sagrinati C, Angelotti ML, Ballerini L, Parente E, Romagnani P, Lazzeri E, Lasagni L. Ronconi E, et al. G Ital Nefrol. 2009 Nov-Dec;26(6):660-9. G Ital Nefrol. 2009. PMID: 19918748 Review. Italian.

• Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).

  D'Agati VD. D'Agati VD. Kidney Int. 2008 Feb;73(4):399-406. doi: 10.1038/sj.ki.5002655. Epub 2007 Nov 7. Kidney Int. 2008. PMID: 17989648 Review.

Cited by

• Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice.

  Qiu W, Zhou Y, Jiang L, Fang L, Chen L, Su W, Tan R, Zhang CY, Han X, Yang J. Qiu W, et al. PLoS One. 2012;7(7):e41391. doi: 10.1371/journal.pone.0041391. Epub 2012 Jul 19. PLoS One. 2012. PMID: 22848482 Free PMC article.

• Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.

  Kuppe C, Gröne HJ, Ostendorf T, van Kuppevelt TH, Boor P, Floege J, Smeets B, Moeller MJ. Kuppe C, et al. Kidney Int. 2015 Nov;88(5):990-8. doi: 10.1038/ki.2015.116. Epub 2015 Apr 8. Kidney Int. 2015. PMID: 25853334

• Urine podocyte mRNAs mark disease activity in IgA nephropathy.

  Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S. Fukuda A, et al. Nephrol Dial Transplant. 2015 Jul;30(7):1140-50. doi: 10.1093/ndt/gfv104. Epub 2015 May 8. Nephrol Dial Transplant. 2015. PMID: 25956757 Free PMC article.

• Oxidative stress in hypertension: role of the kidney.

  Araujo M, Wilcox CS. Araujo M, et al. Antioxid Redox Signal. 2014 Jan 1;20(1):74-101. doi: 10.1089/ars.2013.5259. Epub 2013 Apr 30. Antioxid Redox Signal. 2014. PMID: 23472618 Free PMC article. Review.

• Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.

  Kim JS, Han BG, Choi SO, Cha SK. Kim JS, et al. Biomed Res Int. 2016;2016:1630365. doi: 10.1155/2016/1630365. Epub 2016 Mar 21. Biomed Res Int. 2016. PMID: 27088082 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal